Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.14M 6,526 sh | Apr 21, 2026 |
| 17 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $7.85M 45.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 16 | Valente ManuelaChief People Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $1,977 380 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 16 | Bradbury Robyn LChief Financial Officer |  CNMCore & Main, Inc.Open-market sale · 10b5-1 plan | SELL | $177K 3,353 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 14 | Gupta VikramSee Remarks |  SYNASYNAPTICS IncOpen-market sale · 10b5-1 plan | SELL | $125K 1,548 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Pearson MarkDirector, President and CEO |  EQHEquitable Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $1.65M 39.7K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 14 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $644K 3,662 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,162 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Camblong JurgiDirector, Chief Executive Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $23K 4,486 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Muken RossPresident | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,955 760 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,165 608 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 13 | Van Well DaanChief Legal Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $3,554 684 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 12 | Bradbury Robyn LChief Financial Officer | CNMCore & Main, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 1,647 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 10 | Sevalia Piyush BSee Remarks |  SITMSITIME CorpOpen-market sale · 10b5-1 plan | SELL | $1.17M 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER |  ELVNEnliven Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $117K 2,441 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $115K 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Lewis BryanDirector, CEO/President |  IDNIntellicheck, Inc.Open-market sale · 10b5-1 plan | SELL | $85K 10.0K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Garateix Ernie JDirector, Chief Executive Officer |  HRTGHeritage Insurance Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $221K 8,034 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Wasechek WayneEVP and CFO |  RYNRAYONIER INCOpen-market sale · 10b5-1 plan | SELL | $62K 2,920 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Gibbons Mary LourdesSVP and Chief Legal Officer |  ESNTEssent Group Ltd.Open-market sale · 10b5-1 plan | SELL | $55K 872 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Gibbons Mary LourdesSVP and Chief Legal Officer | ESNTEssent Group Ltd. Open-market sale · 10b5-1 plan | SELL | $481K 7,628 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 7 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER |  ARLOArlo Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $380K 25.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Llewellyn Lindsay CatherineSEE REMARKS |  LYFTLyft, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 23.7K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS |  AREALEXANDRIA REAL ESTATE EQUITIES, INC.Open-market sale · 10b5-1 plan | SELL | $26K 536 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Garateix Ernie JDirector, Chief Executive Officer | HRTGHeritage Insurance Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $8,521 300 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $289K 500 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Hoffmann MartinCEO |  ONONOn Holding AGOpen-market sale · 10b5-1 plan | SELL | $152K 4,150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 3 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $13K 416 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER | ELVNEnliven Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |